Why Peregrine Absolutely Tanked
Peregine Pharmaceuticals has announced that it is discontinuing its Phase 3 Sunrise trial of bavituximab in patients with previously treated locally advanced or metastatic non-squamous non-small cell lung cancer.
All Work
Chris Lange
Wingstop Sets Up for Secondary Offering
Wingstop plans to offer 5 million shares in a secondary offering valued up to more than $132 million, at the most recent closing price.
Foot Locker Earnings Race Past Estimates
Foot Locker reported better-than-expected fiscal fourth-quarter financial results before the markets opened on Friday.
Gap Guidance Falls Short of Investor Expectations
The Gap, Inc. (NYSE: GPS) reported its fiscal fourth-quarter financial results after the markets closed on Thursday. The company had $0.57 in earnings per share (EPS) on $4.39 billion in revenue versus Thomson Reuters…
Is 45% Revenue Growth Guidance Enough for Palo Alto?
Palo Alto Networks, Inc. (NYSE: PANW) released its fiscal second-quarter financial results prematurely before the markets closed on Thursday. Its shares initially popped higher on the news, but shares were halted after the news.…
What to Expect From Monster Beverage Earnings
Monster Beverage is expected to report its fourth-quarter financial results after the markets close on Thursday.
Restoration Hardware Stumbles Over Business Update
Restoration Hardware issued a business update and released its preliminary fourth-quarter results after the markets closed on Wednesday.
What to Expect From Palo Alto Networks Earnings
Palo Alto Networks is scheduled to report its fiscal second-quarter financial results after the markets close on Thursday.
Wayfair Earnings Beat, but Was It by Enough?
Wayfair released mixed fourth-quarter earnings report before the markets opened on Thursday and shares rose by midday.
Kohl’s Underwhelms With Earnings and Guidance
Kohl's reported its fiscal fourth-quarter financial results before the markets opened on Thursday.
Cybersecurity Short Interest Gains Momentum
The February 12 short interest data have been compared with the previous figures, and short interest for the selected cybersecurity stocks increased.
Short Sellers Have Mixed Views on Social Media
The February 12 short interest data have been compared with the previous report, and short interest was mixed in these selected social media stocks.
Short Interest Rises Across the Board in Major Biotechs
The February 12 short interest data have been compared with the previous report, and short interest increased across the board in these selected biotech stocks.
Major Semiconductor Short Interest Remains Largely Mixed
The February 12 short interest data have been compared with the previous report. On the broad scope, short sellers continue to have mixed views on these semiconductor stocks.
Short Sellers Increase Bets in Major Pharma
The February 12 short interest data have been compared with the previous figures, and for the selected pharmaceutical stocks short interest increased.
Major Oil Short Sellers Become More Selective
With oil prices slumping and global markets showing signs of weakness, short interest is now more important than ever to follow.
Salesforce Wows Investors With Solid Earnings and Guidance
Salesforce.com, Inc. (NYSE: CRM) reported its fiscal fourth-quarter financial results after the markets closed on Wednesday. The company had $0.19 in earnings per share (EPS) on $1.81 billion in revenue compared to consensus estimates…
What to Look for in Kohl’s Earnings
Kohl’s Corp. (NYSE: KSS) is scheduled to report its fiscal fourth-quarter financial results before the markets open on Thursday. Thomson Reuters consensus estimates are calling for $1.56 in earnings per share (EPS) on $6.39…
What to Expect From Best Buy Earnings
Best Buy is expected to report its fiscal fourth-quarter financial results before the markets open on Thursday.
Why Credit Suisse Now Likes GM Handily Over Ford
Credit Suisse issued calls on Ford, General Motors and Delphi Automotive on Wednesday, citing that auto volumes have reached a peak in the United States.